The FIS Doping Panel found Cross-Country skier Sergey Shiryaev (RUS) to
have committed an anti-doping rule violation contrary to Articles 2.1 of
the FIS Anti-Doping Rules. He tested positive for the use of the
Prohibited Substance Erythropoietin (EPO), identified on the WADA
Prohibited List 2007 in Class S2 Hormones and related Substances during
a doping control on 21st February 2007 in Sapporo (JPN).
For a first-time violation, the athlete was sanctioned to a two-year
period of ineligibility. The period of ineligibility commences as from
the date of the publication and communication of this decision to the
Russian Ski Association on 28th May 2007 with credit for the period of
provisional suspension from 4th March 2007 to 27th May 2007. The athlete
is therefore ineligible to participate in any capacity in an event or
activity authorized or organized by FIS or any National Ski Association
from 28th May 2007 until 4th March 2009 and his results shall be
annulled from the date on which the Prohibited Substance was found.
Although it is not a requirement of the FIS Anti-Doping Rules that the
member National Ski Association enters into proceedings in an
international doping case, the Russian Ski Association has chosen to do
so in this case. Their enquiries led to sanctions against two coaches
Alexander Bazajchenko and Anatoly Tchepalov in addition to the athlete.
Since these decisions conform to the regulations of the FIS Anti-Doping
Rules that are compiled in accordance with the World Anti-Doping Code,
the FIS Doping Panel sees no reason to change these decisions.
As a result, the FIS Doping Panel noted that given the prompt and
thorough actions of the Russian Ski Association and the Russian Ski
Cross-Country Federation, both should be recognized for their efforts
for doping-free sport.
Secondly, the FIS Doping Panel found Cross-Country skiers Andrey
Kondryshev (KAZ) and Yevgeniy Koschevoy (KAZ) to have committed an
anti-doping rule violation contrary to Article 2.1 of the FIS
Anti-Doping Rules. Both tested positive for the use of the Prohibited
Substance Testosterone, identified on the WADA Prohibited List 2007 in
Class S1b Endogenous Anabolic Androgenic Steroids, during a WADA
out-of-competition doping control on 12th February 2007 in Otaki (JPN).
